Dr. Öğr. Üyesi Olgu Erkin Çınar

Cardio-Hematology Crossroads: A Diffuse Large B-Cell Lymphoma Case Presenting with a Cardiac Mass

The European Research Journal, 2026

DOI 10.18621/eurj.1844523 Frei zugänglicher VolltextQuelle: OpenAlex

A Multi-Targeted Strategy for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: Real-World Outcomes of the ViPOR Regimen

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15145401 PMID 42513315 Frei zugänglicher VolltextQuelle: OpenAlex

Real-World Effectiveness and Renal Safety of Foscarnet for CMV Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15166365 PMID 42652768 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Knowledge, attitudes, and use of artificial intelligence among adult and pediatric hematologists in Türkiye: a national cross-sectional survey

BMC Medical Education, 2026

DOI 10.1186/s12909-026-10065-5 PMID 42958214 Frei zugänglicher VolltextQuelle: ORCID

Coronary bypass for acute coronary syndrome in severe hemophilia A

Turk gogus kalp damar cerrahisi dergisi, 2026

DOI 10.4274/tjtcs.2026.2026-7-38 PMID 42681991 Frei zugänglicher VolltextQuelle: Europe PMC

Risk Factors for Infectious Adverse Events in Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Venetoclax Combinations: A Retrospective Single‐Centre Real‐World Experience

Cancer Reports, 2025

DOI 10.1002/cnr2.70432 PMID 41431240 Frei zugänglicher VolltextQuelle: ORCID

Anemia in the patients with acute myeloid leukemia revisited: Prognostic importance of anemia on treatment-naïve patients

Acta Medica, 2025

DOI 10.32552/2025.actamedica.1135 Frei zugänglicher VolltextQuelle: ORCID

RISK FACTORS FOR INFECTIOUS ADVERSE EVENTS IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH VENETOCLAX COMBINATIONS: A RETROSPECTIVE SINGLE-CENTRE REAL-WORLD EXPERIENCE

2025

DOI 10.22541/au.173677335.55374696/v1 Frei zugänglicher VolltextQuelle: ORCID

Clinical Characteristics and Survival Outcomes in Patients with Essential Thrombocythemia

Indian Journal of Hematology and Blood Transfusion, 2025

DOI 10.1007/s12288-025-02198-2 PMID 42333154 Quelle: ORCID

Comparison of anticoagulant combinations used in granulocyte apheresis

Transfusion and Apheresis Science, 2025

DOI 10.1016/j.transci.2024.104044 PMID 39662126 1 Zitation (Semantic Scholar) Frei zugänglicher VolltextQuelle: ORCID

Long-Term Outcomes of Allogeneic Stem Cell Transplantation for Relapsed/Refractory Hodgkin and Non-Hodgkin Lymphoma: Multi-center Experience from Turkey

Indian Journal of Hematology and Blood Transfusion, 2025

DOI 10.1007/s12288-024-01800-3 PMID 39917483 1 Zitation (Semantic Scholar) Frei zugänglicher VolltextQuelle: ORCID

The role of ruxolitinib in the management of acute GVHD

Transfusion and Apheresis Science, 2025

DOI 10.1016/j.transci.2024.104055 PMID 39719750 1 Zitation (Semantic Scholar) Frei zugänglicher VolltextQuelle: ORCID

Nilotinib-Associated Multiple Silent Arterial Stenoses in a Patient with Chronic Myeloid Leukemia

The Turkish Journal of Hematology, 2024

DOI 10.4274/tjh.galenos.2023.2023.0288 PMID 38153228 3 Zitationen (Semantic Scholar) Frei zugänglicher VolltextQuelle: ORCID

Renin-Angiotensin System and Hematopoietic Stem Cells

Reference Module in Biomedical Sciences, 2024

DOI 10.1016/b978-0-443-15717-2.00122-0 Quelle: ORCID

Coexistence of HHV-8-associated plasmacytic multicentric Castleman disease, Kaposi’s sarcoma, and multiple myeloma in a HIV-negative patient

European Journal of Case Reports in Internal Medicine, 2024

DOI 10.12890/2024_004876 PMID 39372151 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Exploring the distribution and prognostic effect of the ABO blood types of COVID-19 patients during delta and omicron waves: A case control study

Acta Medica, 2023

DOI 10.32552/2023.actamedica.794 Frei zugänglicher VolltextQuelle: ORCID

A novel variant in severe disease of DADA2: involving vasculitic and haematologic features

Scandinavian Journal of Rheumatology, 2023

DOI 10.1080/03009742.2022.2095724 PMID 35852217 1 Zitation (Semantic Scholar) Quelle: ORCID

Enterotoxins A and B produced by Staphylococcus aureus increase cell proliferation, invasion and cytarabine resistance in acute myeloid leukemia cell lines

Heliyon, 2023

DOI 10.1016/j.heliyon.2023.e19743 PMID 37810000 5 Zitationen (Semantic Scholar) Frei zugänglicher VolltextQuelle: ORCID

Hypophosphatemia related to the use of ibrutinib

Journal of Oncology Pharmacy Practice, 2023

DOI 10.1177/10781552231164504 PMID 36987737 Quelle: ORCID

Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: A Cohort Study in the Real-World Setting of a Tertiary Center

The Turkish Journal of Hematology, 2023

DOI 10.4274/tjh.galenos.2023.2023.0089 PMID 37314288 4 Zitationen (Semantic Scholar) Frei zugänglicher VolltextQuelle: ORCID

LONG-TERM OUTCOMES OF ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED/REFRACTORY HODGKIN AND NON-HODGKIN LYMPHOMA: MULTI-CENTER EXPERINCE FROM TURKEY

Hematology Transfusion and Cell Therapy, 2023

DOI 10.1016/j.htct.2023.09.031 Frei zugänglicher VolltextQuelle: OpenAlex

Event-free Survival in Patients with Chronic Myeloid Leukemia Receiving Front-line Imatinib Mesylate

Acta Medica, 2022

DOI 10.32552/2022.actamedica.745 Frei zugänglicher VolltextQuelle: ORCID

Comment on Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 2022, 58, 874

Medicina, 2022

DOI 10.3390/medicina58111575 PMID 36363532 6 Zitationen (Semantic Scholar) Frei zugänglicher VolltextQuelle: ORCID

Covid-19 Related Fatality and Risk Factors in Multiple Myeloma: A Multicenter Cohort Study

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi, 2022

DOI 10.4999/uhod.226339 Quelle: ORCID

Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation

Turkish Journal of Medical Sciences, 2022

DOI 10.55730/1300-0144.5328 PMID 36161632 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Prophylactic Central Nervous System Irradiation Is Not Indispensable in Adult Patients with Acute Lymphoblastic Leukemia: A Multicenter Retrospective Cohort Study

The Turkish Journal of Hematology, 2022

DOI 10.4274/tjh.galenos.2022.2021.0680 PMID 35445593 Frei zugänglicher VolltextQuelle: ORCID

Publication pandemic

European Respiratory Journal, 2022

DOI 10.1183/13993003.congress-2022.3270 Quelle: ORCID

Central nervous system involvement in patients with acute myeloid leukemia

Turkish Journal of Medical Sciences, 2021

DOI 10.3906/sag-2103-127 PMID 33932973 9 Zitationen (Semantic Scholar) Frei zugänglicher VolltextQuelle: ORCID

Perspectives for immune plasma treatment of COVID-19

Turkish Journal of Medical Sciences, 2021

DOI 10.3906/sag-2005-410 PMID 32718128 5 Zitationen (Semantic Scholar) Frei zugänglicher VolltextQuelle: ORCID

The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients

Turkish Journal of Medical Sciences, 2021

DOI 10.3906/sag-2103-72 PMID 33878857 10 Zitationen (Semantic Scholar) Frei zugänglicher VolltextQuelle: ORCID

Covid-19 Pandemi Raporu (20 Mart-20 Kasım 2020)

2021

Quelle: OpenAlex

İmmün (Konvalesan) Plazma Tedavisi

Turkiye Klinikleri Hematology - Special Topics, 2021

Quelle: OpenAlex

Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis

Transfusion and Apheresis Science, 2020

DOI 10.1016/j.transci.2020.102821 PMID 32487513 48 Zitationen (Semantic Scholar) Frei zugänglicher VolltextQuelle: ORCID

Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma

Transfusion and Apheresis Science, 2020

DOI 10.1016/j.transci.2020.102871 PMID 32694044 63 Zitationen (Semantic Scholar) Frei zugänglicher VolltextQuelle: ORCID

COVID-19 Pandemisi Döneminde Hodgkin Lenfoma Yönetimi

Türkiye Klinikleri COVID - 19, 2020

Quelle: OpenAlex

Some concerns and improvements from Turkey

Annals of the Rheumatic Diseases, 2018

DOI 10.1136/annrheumdis-2017-211963 PMID 28798052 Quelle: ORCID

Akut Myeloid Lösemi Hastalarında İndüksiyon Kemoterapisinin Lösemi İlişkili Anemiye Etkisi

Hacettepe University Institutional Repository (hacettepe.edu.tr), 2018

Frei zugänglicher VolltextQuelle: OpenAlex